Cite
HARVARD Citation
Udyavar, A. et al. (n.d.). 338 Emerging insights on the association of tumor molecular phenotype with clinical benefit in metastatic colorectal cancer (mCRC) subjects treated with AB928 + modified FOLFOX-6 (mFOLFOX-6). Journal for immunotherapy of cancer. pp. A206-A207. [Online].